Registration Strip Icon for monitor Surveillez plusieurs cotations en temps réel des principales bourses, telles que Euronext Paris, NASDAQ, NYSE, AMEX, Bovespa et plus encore.

GLGC

Gene Logic Inc. (MM) (GLGC)

Gene Logic Inc. (MM)
De:
Trier par:
 Showing the most relevant articles for your search:NASDAQ:GLGC
DateHeureSourceTitreSymboleSociété
20/12/200723h18Edgar (US Regulatory)Gene Logic Inc - Current report filing (8-K)NASDAQ:GLGCGene Logic Inc. (MM)
18/12/200721h20Edgar (US Regulatory)Gene Logic Inc - Statement of Changes in Beneficial Ownership (4)NASDAQ:GLGCGene Logic Inc. (MM)
14/12/200723h00Business WireGene Logic Inc. Completes Sale of Genomics Assets to Ocimum BiosolutionsNASDAQ:GLGCGene Logic Inc. (MM)
11/12/200712h00Business WireGene Logic Shareholders Approve Genomics Assets Sale and Company Name Change to Ore PharmaceuticalsNASDAQ:GLGCGene Logic Inc. (MM)
09/11/200721h42Edgar (US Regulatory)Gene Logic Inc - Quarterly Report (10-Q)NASDAQ:GLGCGene Logic Inc. (MM)
05/11/200722h24Edgar (US Regulatory)Gene Logic Inc - Proxy Statement (definitive) (DEF 14A)NASDAQ:GLGCGene Logic Inc. (MM)
26/10/200722h55Edgar (US Regulatory)Gene Logic Inc - Proxy Statement - Notice of Shareholders Meeting (preliminary)NASDAQ:GLGCGene Logic Inc. (MM)
25/10/200712h03Edgar (US Regulatory)Gene Logic Inc - Additional Proxy Soliciting Materials (definitive) (DEFA14A)NASDAQ:GLGCGene Logic Inc. (MM)
18/10/200723h26Edgar (US Regulatory)Gene Logic Inc - Amended Current report filing (8-K/A)NASDAQ:GLGCGene Logic Inc. (MM)
31/07/200719h00Business WireGene Logic Recruits Pharmaceutical Executive as Senior Vice President of Clinical DevelopmentNASDAQ:GLGCGene Logic Inc. (MM)
27/07/200714h45Business WireGene Logic Drug Candidate Shows Positive In Vivo Test ResultsNASDAQ:GLGCGene Logic Inc. (MM)
27/07/200712h00Business WireGene Logic Reports Second Quarter 2007 Financial ResultsNASDAQ:GLGCGene Logic Inc. (MM)
23/07/200717h00Business WireGene Logic to Announce Second Quarter 2007 Financial Results on July 27, 2007NASDAQ:GLGCGene Logic Inc. (MM)
28/06/200712h00Business WireGene Logic Enters Into Agreement with Lundbeck to Discover New Development Paths for Clinical Drug CandidatesNASDAQ:GLGCGene Logic Inc. (MM)
18/06/200717h15Business WireGene Logic Collaboration Reveals Genomic Predictors of Parkinson's DiseaseNASDAQ:GLGCGene Logic Inc. (MM)
10/05/200720h10Business WireGene Logic and Abbott Enter Collaboration to Discover New Development Paths for Multiple Clinical Drug CandidatesNASDAQ:GLGCGene Logic Inc. (MM)
27/04/200712h00Business WireGene Logic Reports First Quarter 2007 Financial ResultsNASDAQ:GLGCGene Logic Inc. (MM)
20/04/200712h00Business WireGene Logic to Announce First Quarter 2007 Financial Results on April 27, 2007NASDAQ:GLGCGene Logic Inc. (MM)
16/04/200722h42Business WireGene Logic Promotes Dr. Thomas Barnes to Lead Drug Repositioning Discovery EffortsNASDAQ:GLGCGene Logic Inc. (MM)
11/04/200722h07Business WireGene Logic Board Elects Two New DirectorsNASDAQ:GLGCGene Logic Inc. (MM)
22/03/200711h00Business WireGene Logic Names New CEONASDAQ:GLGCGene Logic Inc. (MM)
09/11/200613h00Business WireGene Logic Reports Third Quarter 2006 Financial ResultsNASDAQ:GLGCGene Logic Inc. (MM)
07/11/200613h00Business WireGene Logic to Announce Third Quarter 2006 Financial Results on November 9, 2006NASDAQ:GLGCGene Logic Inc. (MM)
12/10/200613h00Business WireGene Logic Enters into Agreement with Lilly to Discover New Development Paths for Multiple Clinical Drug CandidatesNASDAQ:GLGCGene Logic Inc. (MM)
22/09/200613h00Business WireGene Logic Provides Update on Business ReviewNASDAQ:GLGCGene Logic Inc. (MM)
10/08/200613h00Business WireGene Logic Provides the FDA with Access to Toxicogenomics Data and Analysis Systems for Reviewing Voluntary Genomic Data SubmisNASDAQ:GLGCGene Logic Inc. (MM)
04/08/200613h00Business WireGene Logic Reports Second Quarter 2006 Financial ResultsNASDAQ:GLGCGene Logic Inc. (MM)
01/08/200622h15Business WireGene Logic Restructures Genomics DivisionNASDAQ:GLGCGene Logic Inc. (MM)
26/07/200613h00Business WireGene Logic to Announce Second Quarter 2006 Financial Results on August 4, 2006NASDAQ:GLGCGene Logic Inc. (MM)
22/06/200613h30Business WireGene Logic to Realize Lower-Than-Expected Revenue for Its Genomics Division; Financial Guidance WithdrawnNASDAQ:GLGCGene Logic Inc. (MM)
 Showing the most relevant articles for your search:NASDAQ:GLGC